- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06814691
Effects on In-Game Decision Making Processes
February 10, 2025 updated by: hazal genc, Istanbul Medipol University Hospital
Evaluation of Analytical Thinking Skills and Reaction Tests of Female Football Players on Performance: Effects on In-Game Decision Making Processes
This study aims to investigate the effects of analytical thinking skills and reaction speed on performance in female football players.
Study Overview
Status
Completed
Conditions
Detailed Description
This study aims to investigate the effects of analytical thinking skills and reaction speed on performance in female football players.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Bahçehir University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The footballers who will take part in the study will be selected from players between the ages of 18-30, who are actively playing in professional football teams and have at least two years of experience.
Description
Inclusion Criteria:
- Accepting the voluntary basis
- To be between the ages of 18-35
- To take part in professional football clubs
- Not having suffered any serious injury in the last 6 months
- To be able to participate in the Tampa Kinesiophobia Scale
- To be able to actively participate in technology-based tests such as decision-making simulations and Blazepod
Exclusion Criteria:
- Not accepting the voluntary basis
- Individuals who have had a surgical procedure in the last six months
- Use of NSAIDs and similar disease modifying drugs in the last month (Diaserein, Glucosamine etc.)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
football player
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of Analytical Thinking and Decision-Making Processes
Time Frame: day 1
|
Female football players' analytical thinking skills will be evaluated through decision-making simulations and video-based training (VBT).
|
day 1
|
|
Assessment of Analytical Thinking and Decision-Making Processes-Accuracy
Time Frame: day 1
|
Female football players' analytical thinking skills will be evaluated through decision-making simulations and video-based training (VBT).
|
day 1
|
|
Assessment of Analytical Thinking and Decision-Making Processes-Error Rates
Time Frame: day 1
|
Female football players' analytical thinking skills will be evaluated through decision-making simulations and video-based training (VBT).
|
day 1
|
|
Tampa Scale of Kinesiophobia-Reaction Times
Time Frame: day 1
|
The Tampa Scale of Kinesiophobia is a 17-item scale developed to assess fear of movement and reinjury.
It includes parameters related to work activities, injury/reinjury, and fear-avoidance behaviors.
The scale uses a 4-point Likert scoring system (1 = Strongly Disagree, 4 = Strongly Agree).
After reversing the scores of items 4, 8, 12, and 16, a total score is calculated, ranging from 17 to 68, where higher scores indicate greater kinesiophobia.
|
day 1
|
|
Reaction Time Measurement (Using Blazepod)
Time Frame: day 1
|
Blazepod devices will be used to measure the reaction speed and agility of female football players.
Pods will be randomly placed and programmed to flash at specific intervals.
Participants will be required to respond quickly to the flashing pods, with their reaction times recorded in milliseconds.
Statistical data such as correct and incorrect response rates will also be obtained.
|
day 1
|
|
Y-Balance Test
Time Frame: day 1
|
Evaluates balance by measuring reach distances in anterior, posteromedial, and posterolateral directions.
|
day 1
|
|
Push-Up Test
Time Frame: day 1
|
Assesses upper body strength and endurance based on the number of push-ups performed.
|
day 1
|
|
Seated Ball Throw Test
Time Frame: day 1
|
Measures upper body power by recording the distance a seated participant can throw a ball.
|
day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 6, 2025
Primary Completion (Actual)
January 6, 2025
Study Completion (Actual)
February 2, 2025
Study Registration Dates
First Submitted
December 21, 2024
First Submitted That Met QC Criteria
February 3, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 10, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-85646034-604.01-93402
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.